Prediction of nodal metastasis and prognosis in breast cancer: A neural model

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2735-2741

  Naguib, R N G ^a   Adams, A E ^a   Horne, C H W ^b   Angus, B ^b   Smith, A F ^b   Sherbet, G V ^a   Lennard, T W J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Axiliary dissection; Lymph nodes; Neural networks; Survival analysis

Indexed keywords

TUMOR MARKER;

ARTICLE; ARTIFICIAL NEURAL NETWORK; AXILLARY LYMPH NODE; BREAST CANCER; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIMULATION; TREATMENT PLANNING;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; LYMPHATIC METASTASIS; NEURAL NETWORKS (COMPUTER); PROGNOSIS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0030764424     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy .The Lancet 339: 71-85, 1992.
2. Rutgers E.J.T: Breast cancer questions for future trials. Eur J Surg Oru 21: 237-239, 1995.
3. Downs J, Harrison RF and Cross SS: Evaluating a neural network decision support tool for the diagnosis of breast cancer In: Barahone P, Stefanelli M and Wyatt M, Artificial Intelligence in Medecine Lecture Notes inArtificial Intelligence 934 (Berlin: Springer-Verlag) 239-250.
4. Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M and Osborne CK: Prognostic factors: rationale and methods of analysis and integrationBreasf Cancer Res Treaf 32: 105-112, 1994.
5. Fausett L: Fundamentals of neural networks-architectures, algorifhms and applications, (Englewood Cliffs NJ: Prentice-Hall), 1994.
6. Henry L, Angus B, Lennard TWJ, Hennessy C, Wright C, Henry JA, Andersen J and Horne CHW: New monoclonal antibodies to oestrogen and progesterone receptor: characterisation and clinical studies in human breast cancer. J Pathol Suppl 169: 168A, 1993.
7. Rayter Z: Steroid receptors in breast cancer. Br J Surg 178: 528-535, 1991.
8. Ostrowski JL, Sawan A, Henry L, Wright C, Henry JA, Hennessy C, Lennard TWJ, Angus B and Horne CHW: p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 164: 75-81, 1991.
9. Sawan A, Hermessy C., Lascu I, Veron M, Wright C, Henry JA, Lermard TWJ, Home CHW and Angus B: Antirnetastatic and oncosuppressor genes expression in human breast cancer: prognostic significance of nm23 and p53 using paraffin section irnrnunohistochernistry. Path Suppl 169: 167A, 1993.
10. Sawan A, Randall B, Angus B, Wright C, Henry JA, Ostrowski J, Hennessy C, Lennard TWJ, Corbett I and Home CHW: Retinoblastorna and p53 gene expression related to relapse and survival in human breast cancer: an imrnunohistochernical study. J Pathol 168: 23-28, 1992.
11. Anderson JJ, Tiniakos D, Home GM, Mellon K, Angus B and Home CHW: Production and characterisation of retinoblastoma gene product specific monoclonal antibodies effective for use on formalin- fixed, paraffin embedded tumour tissue. J Pathol Suppl 172: 135A, 1994.
12. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ and Home CHW: Determination of the prognostic value of CyclinD1 overexpression in breast cancer. Oncogene 11: 885-891, 1995.
13. Hermessy C, Henry JA, May FEB, Westley BR, Angus B and Lermard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991.
14. Sawan A, Lascu I, Veron M, Anderson JJ, Wright C, Horne CHW and Angus B: NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an imrnunohistochemical study. J Pathol 172: 27-34, 1994.
15. Kohonen T: Seyorganisation and associative memory, (Berlin: Springer-Verlag), 1984.
16. De Laurentiis M and Ravdin PM: Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Res Treat 32: 113-118, 1994.
17. Naguib RNG, Adams AE, Home CHW, Angus B, Sherbet GV and Lennard TWJ: Neural networks in the prediction of nodal metastasis in breast cancer Anticancer Res 15 Suppl 5A: 1681-1682, 1995.
18. Robinson IA, McKee G, Nicholson A, D'Arcy J, Jackson PA, Cook MG and Kissin MW: Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. The Lancet 343: 947-949, 1994.
19. Crawford DJ, Lope-Pihie A, Cowan S, George WD and Leake RE: Pre-operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates. Br J Surg 72: 991-993, 1985.
20. Kuenen-Boumeester V, Van Der Kwast TH, Van Laarhoven H and Henzen-Longmans S: Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears. J Clin Pathol 44: 208- 210, 1991.
21. Brotherick I, Lennard TWJ, Cook S, Johnstone R, Angus B, Withereik MP and Shenton BK: Use of the biotinylated antibody DAKO-ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells Cytometry 20: 74-80.
22. Carr M, May FEB, Lennard TWJ, Westley BR: Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription polymerase chain reaction. Br J Cancer 72(6): 1427- 1434, 1995.
23. Naguib RNG, Robinson MC, Apakama I, Neal DE and Hamdy FC: Neural network analysis of prognostic markers in prostate cancer. Br J Urol 77 Suppl 1: pp. 50, 1996.
24. Cox DR: Regression models and life-tables. J Roy Sfat Soc.[B] 34: 187-200, 1972.
25. Erlichman C, Warde P, Gadalla T, Ciampi A and Baskerville T: RECAMP analysis of prognostic factors in patients with stage III breast cancer. Breast Cancer Res Treat 16: 231-242, 1990.